Immunic (IMUX) Change in Account Payables (2013 - 2026)

Immunic has reported Change in Account Payables for 14 years, with the latest figure at $1.1 million in Q1 2026.

• Quarterly Change in Account Payables rose 152.38% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 702.6% YoY) and the FY2025 annual result came in at $1.2 million, down 60.67% from the prior year.
• Change in Account Payables eased to $1.1 million in Q1 2026 per IMUX's latest filing, from $2.2 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $2.3 million in Q4 2024 and troughed at -$2.1 million in Q3 2024.
• A 5-year average of $417000.0 and a median of $986000.0 in 2023 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 602.27% in 2023, down 530.77% in 2023.
• Over 5 years, Change in Account Payables stood at -$352000.0 in 2022, then soared by 602.27% to $1.8 million in 2023, then increased by 28.62% to $2.3 million in 2024, then slipped by 4.84% to $2.2 million in 2025, then tumbled by 49.58% to $1.1 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $1.1 million, $2.2 million, and -$31000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.